[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
The World in Medicine
May 10, 2000

Promising Alzheimer Drug

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;283(18):2379. doi:10.1001/jama.283.18.2379-JWM00003-3-1

New data show that an acetylcholine-preserving drug may halt or lessen cognitive, functional, and behavioral symptoms associated with Alzheimer disease.

In a multicenter study of 353 patients with mild to moderate Alzheimer disease, those treated with 24 mg/d of galantamine maintained or improved their scores on the Alzheimer's Disease Assessment Scale during a 1-year period. The scale measures memory, language, orientation, and other aspects of cognition. Patients in the study also maintained activities of daily functioning for a year. The data were presented last month at the Stockholm/Springfield Symposium in Sweden.

First Page Preview View Large
First page PDF preview
First page PDF preview
×